QUEBEC CITY, March 20, 2012 /PRNewswire/ - Aeterna Zentaris
Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce
its fourth quarter and full year 2011 financial and operating
results on Tuesday, March 27, 2012.
The Company will host a conference call and webcast to discuss
these results on Wednesday, March 28
at 8:30 a.m., Eastern Time.
Participants may access the live webcast via the Company's
website at www.aezsinc.com in the "Newsroom" section, or by
telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside
Canada, 888-231-8191. A replay of
the webcast will also be available on the Company's website for a
period of 30 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a late-stage oncology drug development
company currently investigating potential treatments for various
cancers including colorectal, multiple myeloma, endometrial,
ovarian, prostate and bladder cancer. The Company's innovative
approach of "personalized medicine" means tailoring treatments to a
patient's specific condition and to unmet medical needs. Aeterna
Zentaris' deep pipeline is drawn from its proprietary discovery
unit providing the Company with constant and long-term access to
state-of-the-art therapeutic options. For more information please
visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.